BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25183048)

  • 1. SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) 2014.
    Garcia-Carbonero R; JImenez-Fonseca P; Teulé A; Barriuso J; Sevilla I;
    Clin Transl Oncol; 2014 Dec; 16(12):1025-34. PubMed ID: 25183048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018).
    González-Flores E; Serrano R; Sevilla I; Viúdez A; Barriuso J; Benavent M; Capdevila J; Jimenez-Fonseca P; López C; Garcia-Carbonero R
    Clin Transl Oncol; 2019 Jan; 21(1):55-63. PubMed ID: 30535553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours (GEP NETS).
    García-Carbonero R; Salazar R; Sevilla I; Isla D
    Clin Transl Oncol; 2011 Aug; 13(8):545-51. PubMed ID: 21821488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
    Yin F; Wu ZH; Lai JP
    World J Gastroenterol; 2022 May; 28(17):1751-1767. PubMed ID: 35633912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polish diagnostic and therapeutic guidelines in gastroenteropancreatic neuroendocrine tumors (GEP NET)].
    Kos-Kudła B;
    Endokrynol Pol; 2006; 57(3):267-72. PubMed ID: 17111342
    [No Abstract]   [Full Text] [Related]  

  • 6. SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022).
    Castillón JC; Gordoa TA; Bayonas AC; Carretero AC; García-Carbonero R; Pulido EG; Fonseca PJ; Lete AL; Huerta AS; Plazas JG
    Clin Transl Oncol; 2023 Sep; 25(9):2692-2706. PubMed ID: 37204633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine tumor disease: an evolving landscape.
    Frilling A; Akerström G; Falconi M; Pavel M; Ramos J; Kidd M; Modlin IM
    Endocr Relat Cancer; 2012 Oct; 19(5):R163-85. PubMed ID: 22645227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose?
    Fottner C; Ferrata M; Weber MM
    Rev Endocr Metab Disord; 2017 Dec; 18(4):393-410. PubMed ID: 29256148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
    Ito T; Masui T; Komoto I; Doi R; Osamura RY; Sakurai A; Ikeda M; Takano K; Igarashi H; Shimatsu A; Nakamura K; Nakamoto Y; Hijioka S; Morita K; Ishikawa Y; Ohike N; Kasajima A; Kushima R; Kojima M; Sasano H; Hirano S; Mizuno N; Aoki T; Aoki T; Ohtsuka T; Okumura T; Kimura Y; Kudo A; Konishi T; Matsumoto I; Kobayashi N; Fujimori N; Honma Y; Morizane C; Uchino S; Horiuchi K; Yamasaki M; Matsubayashi J; Sato Y; Sekiguchi M; Abe S; Okusaka T; Kida M; Kimura W; Tanaka M; Majima Y; Jensen RT; Hirata K; Imamura M; Uemoto S
    J Gastroenterol; 2021 Nov; 56(11):1033-1044. PubMed ID: 34586495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine neoplasms of the gastrointestinal tract.
    Schott M; Klöppel G; Raffel A; Saleh A; Knoefel WT; Scherbaum WA
    Dtsch Arztebl Int; 2011 May; 108(18):305-12. PubMed ID: 21629514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours).
    Kos-Kudła B; Blicharz-Dorniak J; Strzelczyk J; Bałdys-Waligórska A; Bednarczuk T; Bolanowski M; Boratyn-Nowicka A; Borowska M; Cichocki A; Ćwikła JB; Falconi M; Foltyn W; Handkiewicz-Junak D; Hubalewska-Dydejczyk A; Jarząb B; Junik R; Kajdaniuk D; Kamiński G; Kolasińska-Ćwikła A; Kowalska A; Król R; Królicki L; Krzakowski M; Kunikowska J; Kuśnierz K; Lampe P; Lange D; Lewczuk-Myślicka A; Lewiński A; Lipiński M; Londzin-Olesik M; Marek B; Nasierowska-Guttmejer A; Nawrocki S; Nowakowska-Duława E; Pilch-Kowalczyk J; Rosiek V; Ruchała M; Siemińska L; Sowa-Staszczak A; Starzyńska T; Steinhof-Radwańska K; Sworczak K; Syrenicz A; Szawłowski A; Szczepkowski M; Wachuła E; Zajęcki W; Zemczak A; Zgliczyński W; Zieniewicz K
    Endokrynol Pol; 2017; 68(2):79-110. PubMed ID: 28597909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinico-morphological analysis of the neuroendocrine neoplasms of the gastroenteropancreatic system.
    Delektorskaya VV; Kozlov NA; Chemeris GY
    Klin Lab Diagn; 2013 Oct; (10):48-50, 10-3. PubMed ID: 24640093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Pavel M; Öberg K; Falconi M; Krenning EP; Sundin A; Perren A; Berruti A;
    Ann Oncol; 2020 Jul; 31(7):844-860. PubMed ID: 32272208
    [No Abstract]   [Full Text] [Related]  

  • 14. Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.
    Alexandraki KI; Kaltsas G
    Endocrine; 2012 Feb; 41(1):40-52. PubMed ID: 22124940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromogranin A in diagnosing and monitoring patients with gastroenteropancreatic neuroendocrine neoplasms: a large series from a single institution.
    Massironi S; Rossi RE; Casazza G; Conte D; Ciafardini C; Galeazzi M; Peracchi M
    Neuroendocrinology; 2014; 100(2-3):240-9. PubMed ID: 25428270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroenteropancreatic neuroendocrine (carcinoid) tumors in children.
    Johnson PR
    Semin Pediatr Surg; 2014 Apr; 23(2):91-5. PubMed ID: 24931354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Oberg K; Jelic S;
    Ann Oncol; 2008 May; 19 Suppl 2():ii104-5. PubMed ID: 18456741
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).
    Garcia-Carbonero R; Capdevila J; Crespo-Herrero G; Díaz-Pérez JA; Martínez Del Prado MP; Alonso Orduña V; Sevilla-García I; Villabona-Artero C; Beguiristain-Gómez A; Llanos-Muñoz M; Marazuela M; Alvarez-Escola C; Castellano D; Vilar E; Jiménez-Fonseca P; Teulé A; Sastre-Valera J; Benavent-Viñuelas M; Monleon A; Salazar R
    Ann Oncol; 2010 Sep; 21(9):1794-1803. PubMed ID: 20139156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How should incidental NEN of the pancreas and gastrointestinal tract be followed?
    Ariotti R; Partelli S; Muffatti F; Andreasi V; Della Sala F; Falconi M
    Rev Endocr Metab Disord; 2018 Jun; 19(2):139-144. PubMed ID: 29527619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Concepts in the Management of GEP-NETs: Introduction.
    Iyer R
    Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 6):3-4. PubMed ID: 27167990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.